Literature DB >> 12068029

Anderson-Fabry disease: extrarenal, neurologic manifestations.

Edwin H Kolodny1, Gregory M Pastores.   

Abstract

Mesh：

Year:  2002        PMID： 12068029

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  16 in total

1.  Improvement of sympathetic skin responses under enzyme replacement therapy in Fabry disease.

Authors:  L B Jardim; I Gomes; C B O Netto; D B Nora; U S Matte; F Pereira; M G Burin; L Kalakun; R Giugliani; J Becker
Journal:  J Inherit Metab Dis       Date:  2006-07-27       Impact factor: 4.982

2.  Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study.

Authors:  Andreas Fellgiebel; Martin Mazanek; Catharina Whybra; Michael Beck; Ralf Hartung; Kay-Maria Müller; Armin Scheurich; Paulo R Dellani; Peter Stoeter; Matthias J Müller
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

3.  Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease-A cross-sectional study.

Authors:  Lu Zhao Di; Maxime Pichette; Réginald Nadeau; Daniel G Bichet; Frédéric Poulin
Journal:  Clin Cardiol       Date:  2018-09-20       Impact factor: 2.882

4.  Fabry disease in latin america: data from the fabry registry.

Authors:  J Villalobos; J M Politei; A M Martins; G Cabrera; H Amartino; R Lemay; S Ospina; S Suarez Ordoñez; C Varas
Journal:  JIMD Rep       Date:  2012-07-06

5.  Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests.

Authors:  Marieke Biegstraaten; Ivo N van Schaik; Wouter Wieling; Frits A Wijburg; Carla E M Hollak
Journal:  BMC Neurol       Date:  2010-06-07       Impact factor: 2.474

6.  Decreased nitric oxide bioavailability in a mouse model of Fabry disease.

Authors:  Liming Shu; James L Park; Jaeman Byun; Subramaniam Pennathur; Jessica Kollmeyer; James A Shayman
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

7.  Psychological aspects of patients with Fabry disease.

Authors:  T Wilson Crosbie; Wendy Packman; S Packman
Journal:  J Inherit Metab Dis       Date:  2009-10-31       Impact factor: 4.982

8.  The Influence of Patient-Reported Joint Manifestations on Quality of Life in Fabry Patients.

Authors:  Alexandra Ivleva; Ekaterina Weith; Atul Mehta; Derralynn A Hughes
Journal:  JIMD Rep       Date:  2018-01-30

9.  CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy.

Authors:  L Jardim; L Vedolin; I V D Schwartz; M G Burin; C Cecchin; L Kalakun; U Matte; F Aesse; C Pitta-Pinheiro; J Marconato; R Giugliani
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 10.  Fabry Disease: Recognition, Diagnosis, and Treatment of Neurological Features.

Authors:  Michela Ranieri; Gloria Bedini; Eugenio Agostino Parati; Anna Bersano
Journal:  Curr Treat Options Neurol       Date:  2016-07       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.